Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Energy Industry News TotalEnergies, RWE ink green hydrogen deal to decarbonise Leuna refinery TotalEnergies has taken a significant step toward reducing carbon emissions at its Leuna refinery in Germany by securing… byPallavi MadhirajuMarch 14, 2025